A Aralex Aachen research explorer

Erin Lynn Crowgey Sign in to save

ORCID 0000-0002-2037-0389 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (2)

6× Incyte Corporation, Wilmington, DE, USA
1× 29Incyte Corporation, Wilmington, United States

Papers 7 stored

All · Aachen affiliation only

POSTER: MPN-554: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis
2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

0

citations
POSTER: MPN-481: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia
2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

0

citations
MPN-554: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis
2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

0

citations
MPN-556: Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis
2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

0

citations
MPN-481: Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia
2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

0

citations
POSTER: MPN-556: Mutant Calreticulin-Specific Monoclonal Antibody INCA033989 Produces Molecular Responses That Correlate With Clinical Responses in Patients With Myelofibrosis
2026 Clinical Lymphoma Myeloma & Leukemia article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

0

citations
Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia
2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

10

citations

7 results